Welcome to Broadline Capital

 

 

Founded in 2005, Broadline Capital is a global alternative investment firm primarily focused on impact investments and growth capital in North America and Asia.  At Broadline, we're inspired by champions — people of vision and courage — whose ideas can positively change the world, and who are ready to transform their ideas into the next big, industry-changing company. 

 

When evaluating opportunities, we seek category leaders and category creators that are reshaping their industries. We prefer highly-charged sectors in which innovation, growth, strong margins, and market fragmentation are yielding abundant investment opportunities.  We look for companies that are well-positioned to thrive as the world continues to transition toward an economy increasingly driven by innovation, healthy living, and the pursuit of a more efficient and sustainable way of life. Successful candidates are typically led by management teams who can benefit from Broadline’s established platform, access to industry expertise, and vast network of relationships built over many years.

Broadline’s transaction leaders have spent their entire careers building trust-based relationships globally. They have led some of the most creative deals in the history of their market categories. Their collective experience and relationships help assure that Broadline-sponsored companies have access to expertise and resources to develop to the next level. We believe Broadline’s current opportunities are among the most exciting on the planet.  - Learn why -

 

New York     |     Miami     |     Columbus     |     Hong Kong    |     Shanghai     |     Seoul

 

 Our Approach 

Broadline's proprietary investment process is designed to stretch alpha at every link of the investment value chain — from transaction origination, evaluation, structuring and execution, to business planning, implementation, and financial exit realization. Our past investment success stems from our multi-channel sourcing and disciplined approach to investment selection:

 

  • First, we start with a Top-Down approach to identify highly-charged categories that are positioned to create broad impact as the world transitions toward an economy increasingly driven by innovation, healthy living, and the pursuit of a more efficient and sustainable way of life. 

 

  • Next, we take a Bottom-Up approach to identify niche category leaders and category creators who are helping to reshape their industry, and whose management teams display the credibility and readiness to develop their business to the next level.  We seek less correlated investments by pursuing diversification across an array of industries, geographies, transaction sizes, and market capitalizations.

Our investment leaders are past CEOs and entrepreneurs of successful companies where they created significant value and negotiated quality exits for themselves and their investors. They understand what it takes to build a business from the ground up, because they've been there.  Staying close to our roots as former CEOs and entrepreneurs, we love collaborating with inspired management teams who think and act differently, and who aim to build something truly special.  

 

  Portfolio Highlights  

We invite you to scroll through one or two current case examples below.   If you are a current Broadline registered investor, click on the "Investor Login" button at the top of the website for management updates and reports from companies in your investment portfolio and to review examples from our current pipeline of prospective new opportunities.

 

Portfolio Example: Healthcare & Medical Technology

Non-invasive Endoscopic Medical Devices

Founded in 2006, EndoSphere is a medical technology company that has developed a first-in-class, non-invasive medical device that endoscopically treats one of the world's largest healthcare issues: Metabolic Diseases including Obesity and Type 2 Diabetes. Endosphere's flagship device, the SatiSphere™ system, is incisionless, reversible and repeatable. In clinical studies, the SatiSphere™ device has enabled obese patients to achieve significant Excess Weight Loss (EWL) without the need for surgery or medication, providing an alternative to the more invasive treatments in today's market. In contrast to traditional anti-obesity treatments such as "restrictive devices", EndoSphere's patented device represents the first of a new category of devices that function as "physiological amplifiers", meaning it uses the body's natural physiological responses to accelerate satiety and to manage appetite. Its focus is treating the Duodenum, which serves as the body's metabolic control center, playing important roles in multiple functions including digestion, appetite regulation, insulin management, and drug delivery. The first-generation version of the SatiSphere device received CE Mark regulatory approval in 31 countries in 2012, and an improved version of the product has entered the clinical stage of development. EndoSphere's portfolio of patent assets is 100% company-owned, free from any licensing or royalty obligations. The Company received the inaugural "Fierce15" award, named by FierceMedTech, which is an annual industry recognition of the world's top 15 most promising privately-held medical device innovations.  For more information, please visit https://www.EndoSphereInc.com.

Portfolio Example: Sustainability & Energy Storage

World's first carbon free lithium-ion battery cathodes

Founded in 2010, Powermers develops patented advanced materials that increase the performance and safety of Lithium-Ion Batteries.  By replacing traditional deadweight carbon and binders with its patented nano-scale electro-conductive polymers, Powermers expands increases the battery's active material limit, resulting in Increased Specific Energy Performance.  Importantly, the resulting batteries also enjoy significantly Increased Safety, due to reduced thermal runaway. Powermers' innovations enable these safety and performance improvements without sacrificing on power, cycle life, weight, or cost per KWH. Powermers' patented transition metal-based polymers are affordable, containing no precious metals, yet they serve as highly-efficient catalysts -- demonstrating higher catalytic functionality than pure noble-metal catalysts including gold, platinum, and palladium. The performance and safety results have been independently validated by two of the industry's recognized third-party battery testing labs, including the US Army Corps of Engineers' Battery Innovation Facilities (CERL) in Champaign, Illinois, as well as The Ohio State University's Center for Automotive Research in Columbus, Ohio. Powermers owns 100% of its IP asset portfolio, free from licensing or royalty obligations. For more information, please visit https://www.Powermers.com.

 

  Our Team  

Our partners have spent their entire careers building trust-based relationships globally, and have led some of the most creative deals in the history of their respective categories. Their combined investment histories, operating experiences, and vast network of relationships developed over many years, help ensure that Broadline-sponsored companies have access to resources and expertise needed to develop to the next level.

 

  Contact  

At Broadline Capital, we are inspired by champions – people of vision and courage – whose ideas can positively change the world, and who are ready to transform their ideas into the next big, industry-changing companies.  If you share our perspective, we invite you to join us. We look forward to hearing from you.  Inquiries regarding current investment opportunities for qualified and accredited investors should be directed to: Info@BroadlineCapital.com.

   BROADLINE CAPITAL 

MANHATTAN: 1 Rockefeller Plaza, 11th Floor, New York, NY 10020 

MIAMI:  801 Brickell Avenue, 9th Floor, Miami, FL 33131

Broadline ® is a Registered Trademark.

Copyright © Broadline Capital 2005-2019 

All Rights Reserved.